Otc - Active Ingredient
Active Ingredients:(in each teaspoonful 5 ml.) Purpose
Guaifenesin 100 mg ................................................................... Expectorant
The following Structured Product Label (SPL) was submitted to the FDA by Efficient Laboratories Inc for the product Rompe Pecho (NDC 58593-829). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - pregnancy or breast feeding, otc - keep out of reach of children, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredients:(in each teaspoonful 5 ml.) Purpose
Guaifenesin 100 mg ................................................................... Expectorant
Purpose
Expectorant
Uses:
Warnings
Do not exceed recommended dosage.
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Age Dose
adults and children 12 years and over 10 mL (2tsps) every 4 hrs.
children 6 to under 12 years of age 5 mL (1 tsp) every 4 hrs
children under 6 years of age consult a doctor
Inactive Ingredients:
Blue Cohosh root extract, Echinacea root extract, Eucalyptus Oil, Ginkgo Biloba leaf extract, glycerin, Golden Seal Root extract,
Honey, Horehound, Licorice Root extract, Menthol, Methylparaben, Mullein leaf extract, Myrrh gum extract, Potassium Sorbate, Propylene
Glycol, Propylparaben, Slippery Elm Bark extract, Sodium Chloride,Sucralose, Water, Wild Cherry Bark extract and Zinc Sulfate.
Questions or Comments?
305-805-3456 Monday - Friday 9AM to 5PM EST
www.efficientlabs.com
* Please review the disclaimer below.